Sign inJoin waitlistJoin the waitlist

JH

James Heubi

Credentials: · ·

History

Pediatric Gastroenterology
1976–1979
Pediatrics
1973–1976
Indiana University School of Medicine
1969–1973

Research

Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements
Journal of Nutrition · 2001 · Last of 9 authors · 625 citations
Exposure of infants to phyto-oestrogens from soy-based infant formula
The Lancet · 1997 · Last of 4 authors · 519 citations
Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability
American Journal of Clinical Nutrition · 2002 · Last of 7 authors · 382 citations

William Balistreri
37 papers
Ronald Sokol
29 papers
Frederick Suchy
14 papers
KB
Kevin Bove
14 papers
Philip Rosenthal
11 papers
Kathleen Loomes
10 papers
JM
John Magee
9 papers
SK
Saul Karpen
9 papers
Jean Molleston
8 papers
Michael Farrell
8 papers
Robert Squires
8 papers
Benjamin Shneider
7 papers

Grants

Center for Clinical and Translational Science and Training
National Center for Advancing Translational Sciences · UL1
Contact PI · $33M · University of Cincinnati
2015–2025
Short-Term Institutional Research Training Grant
National Institute of Diabetes and Digestive and Kidney Diseases · T35
Contact PI · $1.7M · University of Cincinnati
2002–2024
Cincinnati Center for Clinical and Translational Sciences and Training
National Center for Advancing Translational Sciences · UL1
Contact PI · $9.9M · University of Cincinnati
2009–2015
Cincinnati Center for Clinical and Translational Sciences and Training
National Center for Advancing Translational Sciences · KL2
Contact PI · $1.5M · University of Cincinnati
2009–2015

Clinical trials

Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Principal investigator · Completed · Phase 1, Phase 2
Nordmark Arzneimittel GmbH & Co. KG
2013–2014
Baby Observational and Nutritional Study
Principal investigator · Completed
Seattle Children's Hospital
2011–2015
Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis
Principal investigator · Completed · Phase 3
Mirum Pharmaceuticals, Inc.
2010
Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis
Principal investigator · Completed · Phase 3
Mirum Pharmaceuticals, Inc.
2010–2016